Stay updated on Oral Semaglutide vs Sitagliptin in Diabetes Clinical Trial
Sign up to get notified when there's something new on the Oral Semaglutide vs Sitagliptin in Diabetes Clinical Trial page.

Latest updates to the Oral Semaglutide vs Sitagliptin in Diabetes Clinical Trial page
- CheckyesterdayChange DetectedA banner announces NIH website updates and says that some NIH content may use “Super Intelligence” instead of “Artificial Intelligence” during a transition.SummaryDifference1%

- Check8 days agoChange DetectedThe footer’s site revision indicator changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check15 days agoChange DetectedThe footer revision changes from v3.7.0 to v3.7.1 on the 403 Forbidden page, with no change to study information.SummaryDifference0.2%

- Check36 days agoChange DetectedAccess to the study page is blocked by a 403 Forbidden error page, so the study record cannot be viewed. This appears to be an access-control change rather than an update to the study content or metadata.SummaryDifference21%

- Check57 days agoChange DetectedThe page now displays Revision: v3.6.6, replacing the previous v3.6.5. This reflects a new release of the page content.SummaryDifference0.0%

- Check64 days agoChange DetectedAn NIH grant/contract funding line was added among the study identifiers, indicating funding attribution for the trial.SummaryDifference0.0%

Stay in the know with updates to Oral Semaglutide vs Sitagliptin in Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Semaglutide vs Sitagliptin in Diabetes Clinical Trial page.